5-Methylvanillinsaeure | 58186-50-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 5-Methylvanillinsaeure
• 英文别名: 4-hydroxy-3-methoxy-5-methylbenzoic acid
• CAS: 58186-50-8
• 化学式: C₉H₁₀O₄
• 分子量: 182.176
• InChiKey: DVESAUZFVHFEFU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  66.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  5-Methylvanillinsaeure 、 3-溴丙炔 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 生成 2-propynyl 3-methoxy-5-methyl-4-(2-propynyloxy)benzoate
  参考文献：
  名称：

  AMIDE COMPOUND AND USE THEREOF

  摘要：

  本发明公开了一种酰胺化合物，其化学式如下（1），具有出色的植物病害控制活性。在该式中，X1代表氟原子或甲氧基；X2代表氯原子、溴原子、碘原子、C1-C4烷基或类似物；Z代表氧原子或硫原子；A代表A1-CR11R12R13基团或A2-Cy基团，其中A1和A2各代表单键或类似物，R11和R12分别独立地代表C1-C4烷基，R13代表H、C1-C4烷基或类似物，Cy代表C3-C6环烷基或类似物。

  公开号：

  EP2151431A1
• 作为产物：
  描述：

  2-甲氧基-6-甲基苯酚 在 sodium hydroxide 、 silver(l) oxide 作用下， 生成 5-Methylvanillinsaeure
  参考文献：
  名称：

  Zur Sauerstoffoxidation von Kreosolderivaten in alkalisch-wäßriger Lösung

  摘要：

  DOI：

  10.1007/bf00906232

文献信息

• GLUCOSYRINGIC ACID ANALOGS AS SWEETNESS PROFILE MODIFIERS
  申请人：PepsiCo, Inc.

  公开号：US20180020708A1

  公开（公告）日：2018-01-25

  The present disclosure provides novel sweetener compositions comprising a compound having a structure according to Formula I: wherein R 1 , R 2 , R 3 , and R 4 are described herein. Also provided are methods of modulating sweetness profile of a product by adding a compound of Formula I to the product, such as a beverage product or a food product. For example, the compound described herein can be added to increase the overall sweetness of a nutritive sweetener sweetened beverages; decrease the sweetness time-of-onset for high potency sweeteners such as rebaudioside A; decreasing bitter, metallic and licorice off-notes of high potency sweeteners; and improve the sweet quality of sweetened products.

  本公开提供了包含具有如下式I的结构的化合物的新型甜味剂组合物： 其中R1、R2、R3和R4如本文所述。还提供了通过向产品添加式I的化合物来调节产品的甜味特性的方法，例如饮料产品或食品产品。例如，本文描述的化合物可添加以增加富含甜味剂的饮料的整体甜度；减少高效甜味剂（如甜菊糖A）的甜味起始时间；减少高效甜味剂的苦味、金属味和甘草味等异味；并改善甜味产品的甜味质量。
• Therapeutic Aryl-Amido-Aryl Compounds and Their Use
  申请人：Corcoran Jonathan Patrick Thomas

  公开号：US20120149737A1

  公开（公告）日：2012-06-14

  The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-amido-aryl compounds of the following formula (for convenience, collectively referred to herein as “AAA compounds”), which, inter alia, are (selective) retinoic acid receptor α (RARα) agonists. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to (selectively) activate RARα, and in the treatment of diseases and conditions that are mediated by RARα, that are ameliorated by the activation of RARα, etc., including cognitive disorders, memory impairment, memory deficit, senile dementia, Alzheimer's disease, early stage Alzheimer's disease, intermediate stage Alzheimer's disease, late stage Alzheimer's disease, cognitive impairment, and mild cognitive impairment.

  本发明涉及治疗化合物领域，更具体地涉及以下公式的某些芳基酰胺-芳基化合物（为方便起见，以下统称为“AAA化合物”），其为（选择性）视黄酸受体α（RARα）激动剂。本发明还涉及包含这些化合物的药物组合物，以及利用这些化合物和组合物在体外和体内（选择性地）激活RARα，并用于治疗由RARα介导的疾病和症状，以及通过激活RARα改善的疾病和症状，包括认知障碍、记忆障碍、记忆缺陷、老年性痴呆、阿尔茨海默病、早期阿尔茨海默病、中期阿尔茨海默病、晚期阿尔茨海默病、认知损害和轻度认知损害。
• Fast Degrading Polymers
  申请人：Uhrich Kathryn E.

  公开号：US20090035248A1

  公开（公告）日：2009-02-05

  The invention provides polyanhydrides that degrade in less than 60 hours following topical administration to deliver biologically active compounds.

  该发明提供了聚酸酐，通过局部给药在不到60小时内分解，以释放生物活性化合物。
• DRUGS FOR CHRONIC PAIN
  申请人：Ongini Ennio

  公开号：US20090239832A1

  公开（公告）日：2009-09-24

  The present invention relates to nitrooxyderivatives or salts thereof having the following general formula (I): R—NR 1c —(K) k0 —(B) b0 —(C) c0 —NO 2 (I) wherein c0, b0 and k0 are 0 or 1; R is the radical of an analgesic drug for chronic pain, for instance neurophatic pain; R 1c is H or alkyl with from 1 to 5 carbon atoms; B is such that its precursor is selected from amino acids, hydroxy acids, polyalcohol, compounds; C is a bivalent radical containing an aliphatic, heterocyclic or aromatic radical.

  本发明涉及一种具有以下一般式（I）的硝酰氧衍生物或其盐：R—NR1c—（K）k0—（B）b0—（C）c0—NO2（I），其中c0，b0和k0为0或1；R是用于慢性疼痛，例如神经性疼痛的镇痛药物的基团；R1c为H或具有1至5个碳原子的烷基；B是其前体物被选自氨基酸、羟基酸、多元醇、化合物的基团；C是含有脂肪族、杂环或芳香族基团的二价基团。
• FRUIT EXTRACTS
  申请人：O'Kennedy Niamh

  公开号：US20110206794A1

  公开（公告）日：2011-08-25

  Provided are methods of making an extract of fruit of the Solanaceae family wherein fruit is processed to optimise the platelet aggregation inhibiting activity of the extract. The methods involve preparing a start mix of homogenised fruit; separating a water soluble fraction from fruit solids; filtration of the water soluble fraction; and concentration of active agents in the filtration permeate. The invention also provides fruit extracts manufactured by such methods, and also fruit extracts containing glycolsylated phenolic acid or a phenolic ester, or derivatives thereof; a glycosylated flavonoid; and a nucleoside. The extracts of the invention are useful as medicaments for the treatment or prevention of a medical condition characterised by inappropriate platelet aggregation. In particular, the medicaments may be of use in maintaining heart health by reducing platelet aggregation; benefiting the circulation; and/or normalizing or otherwise benefiting blood flow.